Chemours Company Overview
Chemours Company Target Price
Analysts' 12-month price predictions for CC.
Get informed when a big investor buys or sells
+ FollowShare Price
$18.63
Average Target Price
$28.00
50.3% upside
50.3% upside9 analysts in the last 4 months
High: $30 | Low: $21
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-13 | Alembic Global | $30 | 61% upside |  |
| 2026-05-11 | Morgan StanleyVincent Andrews | $21 | 12.7% upside | |
| 2026-05-11 | RBC Capital | $29 | 55.7% upside | |
| 2026-05-08 | UBS | $30 | 61% upside | |
| 2026-05-06 | Mizuho SecuritiesJohn Roberts | $30 | 61% upside | |
| 2026-04-28 | Truist FinancialPeter Osterland | $30 | 61% upside | |
| 2026-04-10 | RBC CapitalArun Viswanathan | $26 | 39.6% upside | |
| 2026-04-09 | UBS | $29 | 55.7% upside | |
| 2026-04-09 | Truist Financial | $27 | 44.9% upside | |
| 2026-02-23 | Mizuho Securities | $17 |  8.7% downside | |
| 2026-02-23 | JefferiesLaurence Alexander | $17 | 8.7% downside | |
| 2026-02-23 | UBS | $23 | 23.5% upside | |
| 2026-02-23 | BMO Capital | $19 | 2% upside | |
| 2026-02-23 | Morgan StanleyVincent Andrews | $17 | 8.7% downside | |
| 2026-01-21 | Truist Financial | $21 | 12.7% upside | |
| 2026-01-19 | BMO CapitalJohn McNulty | $20 | 7.4% upside | |
| 2026-01-16 | RBC Capital | $18 | 3.4% downside | |
| 2025-11-10 | Truist FinancialPeter Osterland | $18 | 3.4% downside | |
| 2025-10-16 | Mizuho SecuritiesJohn Roberts | $18 | 3.4% downside | |
| 2025-10-14 | RBC Capital | $19 | 2% upside | |
| 2025-10-06 | UBSJoshua Spector | $21 | 12.7% upside | |
| 2025-09-23 | Mizuho SecuritiesJohn Roberts | $19 | 2% upside | |
| 2025-05-07 | UBSJoshua Spector | $17 | 8.7% downside | |
| 2025-04-15 | Mizuho SecuritiesJohn Roberts | $15 | 19.5% downside | |
| 2024-10-11 | RBC CapitalArun Viswanathan | $28 | 50.3% upside | |
| 2024-10-07 | BMO CapitalJohn McNulty | $32 | 71.8% upside | |
| 2024-08-06 | BMO CapitalJohn McNulty | $30 | 61% upside | |
| 2024-06-07 | Mizuho SecuritiesJohn Roberts | $25 | 34.2% upside | |
| 2024-05-29 | UBSRich Hilliker | $31 | 66.4% upside | |
| 2024-04-09 | BMO CapitalJohn McNulty | $34 | 82.5% upside | |
| 2024-04-01 | UBSJoshua Spector | $28 | 50.3% upside | |
| 2024-04-01 | CFRAEmily Nassedd Mitsch | $18 | 3.4% downside | |
| 2024-03-13 | D.A. DavidsonLinda Bolton Weiser | $24 | 28.8% upside | |
| 2023-12-01 | RBC CapitalArun Viswanathan | $40 | 114.7% upside | |
| 2023-10-30 | Morgan StanleyVincent Andrews | $33 | 77.1% upside | |
| 2023-01-10 | RBC CapitalArun Viswanathan | $33 | 77.1% upside | |
| 2022-05-04 | RBC Capital | $48 | 157.6% upside | |
| 2021-05-20 | Bank of America SecuritiesMatthew DeYoe | $42 | 125.4% upside | |
| 2021-05-10 | Morgan StanleyVincent Andrews | $35 | 87.9% upside | |
| 2021-05-06 | Argus ResearchDavid Coleman | $40 | 114.7% upside | |